News Archive

Online tool to visually explore HIV epidemic, AIDSVu.org launched

JUN-01-11 AIDSVu provides a high-resolution view of the geography of HIV in the United States, 30 years into the epidemic. It is an online tool that allows users to visually explore the HIV epidemic alongside critical resources such as HIV testing center locations and NIH-Funded HIV Prevention & Vaccine Trials Sites. Visit AIDSVu.org to try it yourself.

Statistical Methods for Causal Inference in Observational and Randomized Studies

JUN-01-11 Forum/UC Berkeley SPH-Sponsored 3-day Executive-level course: September 26-28, 2011. Registration now open.

MAY-31-11 Read Dr. Anthony Fauci's recent Washington Post article, "After 30 years of HIV/AIDS, real progress and much left to do." Access the article here.

MAY-23-11 The U.S. Food and Drug Administration today approved Incivek (telaprevir) to treat certain adults with chronic hepatitis C. Read the press release here.

MAY-20-11 US Medical Director, Virology unit of Tibotec Therapeutics joins Forum EC.

May-13-11 The U.S. Food and Drug Administration today approved Victrelis (boceprevir) to treat certain adults with chronic hepatitis C. Read the press release here.

MAY-12-11 Today the sponsors of a randomized clinical trial known as HPTN 052, which is evaluating combination antiretroviral therapy for HIV prevention, announced that randomization would halt due to overwhelming evidence of benefit.

MAY-11-11 Congressional Briefing: "Combating the Hidden Epidemic: U.S. Department of Health and Human Services Action Plan for the Prevention and Treatment of Viral Hepatitis"
Thursday, May 12 - Click here to read more.

APR-26-11 On April 27 and 28, the FDA's Antiviral Drugs Advisory Committee will meet to discuss new drug applications for the first in class HCV protease inhibitors, Boceprevir (April 27) and Telaprevir (April 28).

Materials Now Available Here

MAR-25-11 On behalf of the Infectious Diseases Society of America/HIV Medicine Association and the Center for Global Health Policy, you are invited to submit abstracts in the category of HIV/AIDS for presentation at the 49th Annual Meeting of IDSA, October 20-23, 2011 in Boston, Massachusetts.

MAR-14-11 Head of HIV Vaccine Research Unit joins Forum Executive Committee as ANRS (Agence Nationale de Recherche sur le Sida et les hépatites virales) Representative

«
Start
Prev
11
12
13
14
15
16
17
Next
End
»

Page 13 of 17

Online tool to visually explore HIV epidemic, AIDSVu.org launched

Statistical Methods for Causal Inference in Observational and Randomized Studies

Dr. Fauci's Reflections on 30 Years of HIV/AIDS

FDA Approves Second Direct Acting Antiviral For Treatment of Chronic HCV Infection

Dr. David Anderson of Tibotec joins Forum EC

FDA Approves First Direct Acting Antiviral For Treatment of Chronic HCV Infection

HPTN 052 trial confirms ARV treatment is a powerful prevention tool

New Action Plan to Prevent, Care and Treat Viral Hepatitis - Congressional Briefing and Announcement

FDA Antivirals Drugs Advisory Committee Meetings to Discuss the First Direct Acting Antivirals

Invitation to International HIV Investigators to Submit Abstracts For Meeting of IDSA

Dr. Anna Laura Ross joins Forum as ANRS Representative

News

Events